Heparin prevents postischemic endothelial cell dysfunction by a mechanism independent of its anticoagulant activity

Journal of Vascular Surgery

Volumn 17, Issue 2, 1993, Pages 318-327

  Sternbergh III, W Charles ^a   Makhoul, Raymond G ^a   Adelman, Burt ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; CYCLIC GMP; ENDOTHELIUM DERIVED RELAXING FACTOR; HEPARIN; NITROPRUSSIDE SODIUM; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR;

ANIMAL TISSUE; ANTICOAGULATION; ARTICLE; BLOOD VESSEL PERMEABILITY; CELL PROTECTION; CONTROLLED STUDY; DRUG MECHANISM; ENDOTHELIUM CELL; HEPARINIZATION; HINDLIMB; LIMB ISCHEMIA; MALE; MEMBRANE STABILIZATION; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION; VASCULAR ENDOTHELIUM; VASODILATATION; WATER CONTENT;

ANIMAL; COMPARATIVE STUDY; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION, PRECLINICAL; ENDOTHELIUM, VASCULAR; HEPARIN; HINDLIMB; IN VITRO; ISCHEMIA; MALE; NITRIC OXIDE; PERFUSION; RATS; RATS, SPRAGUE-DAWLEY; SUPPORT, U.S. GOV'T, P.H.S.; VASCULAR RESISTANCE; VASODILATION;

EID: 0027479415     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/0741-5214(93)90417-K     Document Type: Article

References (44)

1. Surgical management of severe lower extremity ischemia
2. Heparinization reduces endothelial permeability and hydrogen ion accumulation in a canine skeletal muscle ischemia-reperfusion model
3. Replication of the compartment syndrome in a canine model: experimental evaluation of treatment
4. Pre-ischemic heparinization decreases rat skeletal muscle reperfusion injury
5. 1
6. Scanning electron microscopy of the rat common carotid artery: III
7. The interaction of platelets with a tritium-labeled heparin
8. Potentiation of Cl esterase inhibitor activity by heparin
9. The close relationship of heparin and the vessel wall
10. The temporal relationship between endothelial cell dysfunction and skeletal muscle damage after ischemia and reperfusion
11. Functional coronary microvascular injury evident as increased permeability due to brief ischemia and reperfusion
12. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor
13. Sternbergh WC III, Makhoul RG, Adelman B. Nitric oxide mediated endothelial-dependent vasodilation is selectively attenuated in the post-ischemic extremity. Surgery (in press).
14. Nitric oxide: physiology, pathophysiology, and pharmacology
15. Exogenous magnesium chloride-adenosine triphosphate administration during reperfusion reduces the extent of necrosis in previously ischemic muscle
16. Nitric oxide synthesized from L-arginine regulates vascular tone in the coronary circulation of the rabbit
17. Vasodilator actions of acetylcholine, A23187 and bradykinin in the guinea-pig isolated perfused heart are independent of prostacyclin
18. Skeletal muscle fiber type does not predict sensitivity to post-ischemic damage
19. Ischemia-reperfusion in isolated rat hindquarters
20. Microvascular injury after ischemia and reperfusion in skeletal muscle of exercise-trained rats
21. Acetylcholine-induced vasodilation in rabbit hindlimb is not inhibited by analogues of L-arginine
22. Laboratory monitoring of heparin: effect of reagents and instruments on the activated partial thromboplastin time
23. Effects of heparin in large doses on the extent of myocardial ischemia after acute coronary occlusion in the dog
24. Temporary experimental intracranial vascular occlusion: effect of massive doses of heparin on brain survival
25. Does heparin improve survival in experimental porcine gram-negative shock
26. Preheparinization improves organ function after hemorrhage and resuscitation
27. Heparin decreases ischemia-reperfusion injury in isolated canine gracilis model
28. Suppression by heparin of smooth muscle cell proliferation in injured arteries
29. Suppression of experimental autoimmune diseases and prolongation of allograft survival by treatment of animals with low doses of heparin
30. Angiogenic effect of low molecular weight heparin (Fragmin) in coronary artery disease
31. Control of angiogenesis with synthetic heparin substitutes
32. The production of lipolytic activity in the circulation of the hind limb in response to heparin
33. Heparin, a potent releasing agent of extracellular superoxide dismutase (EC-SOD), suppresses ischemic paw oedema in mice
34. Extracellular superoxide dismutase in the vascular system of mammals
35. Effects of unfractionated heparin, dermatan sulfate and low molecular weight heparin on vessel wall permeability in rabbits
36. Effect of thrombotic and antithrombotic drugs on the surface charge characteristics of canine blood vessels
37. The observation of heparin on endothelium after injection
38. The internalization and release of heparins by cultured endothelial cells: the process is cell source, heparin source, time and concentration dependent
39. The role of oxygen-derived free radicals in ischemia-induced increases in canine skeletal muscle vascular permeability
40. Heparin protects cultured arterial endothelial cells from damage by toxic oxygen metabolites
41. Monoclonal antibody to tumor necrosis factor alpha attenuates cardiopulmonary dysfunction in porcine gram-negative sepsis
42. On the binding of tumor necrosis factor (TNF) to heparin and the release in vivo of the TNF-binding protein I by heparin
43. Tumor necrosis factor alpha/cachectin stimulates eosinophil oxidant production and toxicity toward human endothelium
44. Stimulation by heparin of cGMP production in cultured endothelial cells from spontaneously hypertensive rats